HMH Maestro

Hospitals & Locations

Center for Discovery and Innovation Opens

All Locations

What you need to know

Hackensack Meridian Health’s Center for Discovery and Innovation (CDI) officially opened on May 29, 2019.

CDI is a 250,000-square-foot research facility located at the On3 campus, former home to Hoffmann-LaRoche, in Nutley and Clifton.

The center will focus on three specialty areas:

– Institute for Regenerative Medicine.
– Institute for Cancer and Infectious Disease.
– Institute for Multiple Myeloma.

Funding sources for CDI include the government (ie.: grants from the National Institutes of Health, the National Cancer Institute), individual and corporate philanthropy, venture philanthropy and venture capital.

L to R: David S. Perlin, Ph.D., chief scientific officer and senior vice president, CDI; Sol J. Barer, Ph.D., the founder of Celgene, chair of the Board of Directors of Teva Pharmaceuticals and founding chair of the CDI Board of Trustees; Gordon Litwin, Esq., chair, Hackensack Meridian Health Board of Trustees; Robert C. Garrett, FACHE, CEO, Hackensack Meridian Health; Governor Phil Murphy; David S. Siegel, M.D.,  Ph.D., founding director of the CDI’s Institute for Multiple Myeloma; Andrew Pecora, M.D., chief executive officer, Outcomes Matter Innovations, LLC; Clifton Mayor James Anzaldi; and Township of Nutley Commissioner Thomas J. Evans.

CDI’s Key Researchers